Lausanne, Switzerland, July 12, 2022 - Saphetor, a global precision medicine company and the creator of VarSome, The Human Genomics Community and variant interpretation platform, announced today a partnership with PTC Therapeutics International...

Press Releases News

Saphetor Partners with PTC Therapeutics to advance awareness of clinical programs in rare diseases

By Carl Smith on July 12, 2022

0

Saphetor was featured in Nature Portfolio's Biopharma Dealmakers this week. The article explains how and why Saphetor developed VarSome. You can read the full article here.

Press Releases News

Saphetor in Nature Portfolio's Biopharma Dealmakers

By Carl Smith on April 13, 2022

0

Partnerships VarSome Clinical News

Gencell Pharma S.A.S. to adopt VarSome Clinical for high-throughput analysis of clinical exomes and genomes sequenced on MGI DNBSEQ-G400 and T7 platforms

By Carl Smith on March 29, 2022

0

VarSome sponsored this year'sAmerican College of Medical Genetics Annual Clinical Genetics Meeting, March 22-26.

ACMG Events

VarSome at ACMG 2022

By Carl Smith on March 26, 2022

0

VarSome is sponsoring this year'sAmerican Society of Human Genetics Virtual Annual Meeting, October 18-22.

Events News

VarSome at ASHG 2021

By Carl Smith on October 19, 2021

0

Saphetor was featured in a Forbes article this week, highlighting the companies doing great work in the UK genomics ecosystem. The article covers our founder and CEO, Andreas Massouras, VarSome, and the incredible growth of the company through smart...

News

Saphetor in Forbes

By Carl Smith on September 3, 2021

1

VarSome is sponsoring this year's European Human Genetics Conference, hosted by the European Society of Human Genetics, August 28-31.

Events

VarSome at ESHG 2021

By Carl Smith on August 27, 2021

1